Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene autoleucel (cilta-cel) Out-of-Specification (OOS) in patients with Multiple Myeloma

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date1/28/25 → …